Autonomix Medical Expands Intellectual Property Portfolio with New U.S. Patent Covering Feedback-Guided Precision Neuromodulation and Targeted Therapy Delivery
Autonomix Medical, Inc. announced the issuance of a new U.S. patent (No. 12,714,780) expanding its intellectual property portfolio around systems integrating real-time physiological feedback, sensing, and imaging with controlled therapeutic delivery. The patent covers precision nerve-targeted treatments including neural ablation for cancer pain rel…